Literature DB >> 26071556

Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice.

Fadila Telarevic Cero1, Vigdis Hillestad2, Ivar Sjaastad3, Arne Yndestad4, Pål Aukrust5, Trine Ranheim4, Ida Gjervold Lunde6, Maria Belland Olsen7, Egil Lien8, Lili Zhang2, Solveig Bjærum Haugstad2, Else Marit Løberg9, Geir Christensen2, Karl-Otto Larsen10, Ole Henning Skjønsberg11.   

Abstract

Pulmonary hypertension is a serious condition that can lead to premature death. The mechanisms involved are incompletely understood although a role for the immune system has been suggested. Inflammasomes are part of the innate immune system and consist of the effector caspase-1 and a receptor, where nucleotide-binding oligomerization domain-like receptor pyrin domain-containing 3 (NLRP3) is the best characterized and interacts with the adaptor protein apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC). To investigate whether ASC and NLRP3 inflammasome components are involved in hypoxia-induced pulmonary hypertension, we utilized mice deficient in ASC and NLRP3. Active caspase-1, IL-18, and IL-1β, which are regulated by inflammasomes, were measured in lung homogenates in wild-type (WT), ASC(-/-), and NLRP3(-/-) mice, and phenotypical changes related to pulmonary hypertension and right ventricular remodeling were characterized after hypoxic exposure. Right ventricular systolic pressure (RVSP) of ASC(-/-) mice was significantly lower than in WT exposed to hypoxia (40.8 ± 1.5 mmHg vs. 55.8 ± 2.4 mmHg, P < 0.001), indicating a substantially reduced pulmonary hypertension in mice lacking ASC. Magnetic resonance imaging further supported these findings by demonstrating reduced right ventricular remodeling. RVSP of NLRP3(-/-) mice exposed to hypoxia was not significantly altered compared with WT hypoxia. Whereas hypoxia increased protein levels of caspase-1, IL-18, and IL-1β in WT and NLRP3(-/-) mice, this response was absent in ASC(-/-) mice. Moreover, ASC(-/-) mice displayed reduced muscularization and collagen deposition around arteries. In conclusion, hypoxia-induced elevated right ventricular pressure and remodeling were attenuated in mice lacking the inflammasome adaptor protein ASC, suggesting that inflammasomes play an important role in the pathogenesis of pulmonary hypertension.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  inflammation; innate immunity; pulmonary vasculature

Mesh:

Substances:

Year:  2015        PMID: 26071556     DOI: 10.1152/ajplung.00342.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  24 in total

Review 1.  Inflammasomes: a novel therapeutic target in pulmonary hypertension?

Authors:  Tara Elizabeth Scott; Barbara K Kemp-Harper; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2018-06-27       Impact factor: 8.739

Review 2.  Autophagy and inflammation in chronic respiratory disease.

Authors:  Alexandra C Racanelli; Sarah Ann Kikkers; Augustine M K Choi; Suzanne M Cloonan
Journal:  Autophagy       Date:  2018-02-08       Impact factor: 16.016

Review 3.  Mitochondria in lung disease.

Authors:  Suzanne M Cloonan; Augustine M K Choi
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

4.  A method for evaluating the murine pulmonary vasculature using micro-computed tomography.

Authors:  Michael R Phillips; Scott M Moore; Mansi Shah; Clara Lee; Yueh Z Lee; James E Faber; Sean E McLean
Journal:  J Surg Res       Date:  2016-08-31       Impact factor: 2.192

Review 5.  Inflammasomes link vascular disease with neuroinflammation and brain disorders.

Authors:  Nikolett Lénárt; David Brough; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-02       Impact factor: 6.200

6.  Long-term pulmonary and cardiovascular morbidities of neonatal hyperoxia exposure in mice.

Authors:  Renuka T Menon; Amrit Kumar Shrestha; Corey L Reynolds; Roberto Barrios; Binoy Shivanna
Journal:  Int J Biochem Cell Biol       Date:  2017-12-07       Impact factor: 5.085

Review 7.  Update on novel targets and potential treatment avenues in pulmonary hypertension.

Authors:  John C Huetsch; Karthik Suresh; Meghan Bernier; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-02       Impact factor: 5.464

Review 8.  Pyroptosis-Induced Inflammation and Tissue Damage.

Authors:  Yinan Wei; Ling Yang; Ankit Pandeya; Jian Cui; Yan Zhang; Zhenyu Li
Journal:  J Mol Biol       Date:  2021-10-13       Impact factor: 5.469

Review 9.  Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Authors:  Norbert F Voelkel; Rasa Tamosiuniene; Mark R Nicolls
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-04

Review 10.  Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.

Authors:  Seonmin Lee; Gee-Young Suh; Stefan W Ryter; Augustine M K Choi
Journal:  Am J Respir Cell Mol Biol       Date:  2016-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.